Capula Management LTD Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Capula Management LTD

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $204,817 - $240,352	200 New	200 $210,000
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $7.13 Million - $7.74 Million	10,100 Added 246.34%	14,200 $10.2 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $2.35 Million - $2.97 Million	4,100 New	4,100 $2.82 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $8.23 Million - $11.1 Million	-15,000 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$595.12 - $698.43 $8.93 Million - $10.5 Million	15,000 New	15,000 $10.5 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $425,520 - $502,685	-900 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $402,057 - $493,380	900 New	900 $426,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.